Try, try again: Can a 2nd dose of CAR T cells succeed when the first fails?
The research will help inform how and whether doctors might give second doses of a cellular immunotherapy to patients with intractable blood cancers.
Related Articles
AACR 2025
The American Association for Cancer Research (AACR) annual meeting program covers the latest discoveries across the spectrum of cancer research — from population science and…
RNA “typos” can highlight leukemia cells for immune attack
Fred Hutch and MSK researchers showed that tumors driven by hiccups in RNA processing can’t hid from the immune system. In work published in Cell,…
AACR 2025
The American Association for Cancer Research (AACR) annual meeting program covers the latest discoveries across the spectrum of cancer research — from population science and…
Functional and antigenic landscape of the Nipah virus receptor-binding protein
Nipah virus is a zoonotic virus that spills over to humans and causes infections with a high mortality rate. Deep mutational scanning of the Nipah…
Fine-scale patterns of SARS-CoV-2 spread from identical pathogen sequences
Nature – The analysis of pairs of identical SARS-CoV-2 genome sequences enables characterization of transmission patterns between geographies and age groups.
Managing mountains of genomic data
The sheer volume of genomic sequences of SARS-CoV-2 — a dataset that is orders of magnitude bigger than what’s available for any other pathogen —…
Fewer doses of cancer-preventing HPV vaccine may be as effective as recommended amount: HealthLink
The findings from Fred Hutch Cancer Center suggest next step of exploring whether one dose of the vaccine is enough.
Moving Beyond Cancer to Wellness
The Fred Hutch Survivorship Program is hosting the 19th annual Moving Beyond Cancer to Wellness, a free in-person event for cancer patients, survivors, caregivers, friends,…
Strategies to Assess Risk for Hereditary Cancer in Primary Care Clinics
This cluster randomized clinical trial compares 2 population-based engagement strategies for identifying primary care patients with a hereditary risk of cancer and offering eligible individuals…
Colorectal Cancer and Gut Microbiome: How Fusobacterium nucleatum May be Involved in Disease Progression
Fred Hutch researcher, Orsalem Kahsai, analyzes microbiome data to better understand the relationship between Fusobacterium nucleatum and colorectal cancer. Image credit: Sosun Nayemia